Supply Chain

Pressure to slash drug prices from both the Democratic and Republican presidential candidates, as well as leaders and consumer advocates around the globe, could spur changes to the drug pricing model, according to Fortune.

Many Olympic athletes take advantage of a loophole to the anti-doping rules that ban the use of performance enhancing drugs through a practice known as "legal doping," or taking legal prescription medications that may improve performance, according to NPR.

On Saturday, a white male between the ages of 25-40 stole 19 prescriptions from Kilgore's Pharmacy in Columbia, Mo., according to ABC 17 News.

Abbott today introduced Alinity, a unified platform that links immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening, and molecular diagnostics across a health system.

The rising cost of specialty drugs is the number one driver of healthcare expenses for large employers, according to a survey released Tuesday by the National Business Group on Health.

Ninety percent savings on generic drug costs? It sounds too good to be true — but that's what brothers Geoffrey and Matthew Chaiken are promising with their new technology company Blink Health.

Britain-based AstraZeneca's experimental drug selumetinib failed to show positive results in a late-stage clinical trial for lung cancer, according to Reuters.

There is a large online market for the unauthorized sale of previously used continuous positive airway pressure devices to treat obstructive sleep apnea, according to a recent study published in JAMA Internal Medicine.

The Food and Drug Administration recently approved the CyPass Micro-Stent for the treatment of glaucoma.

Global sourcing for hospitals and IDNs step 4: customization and continued product expansion.